Dr. Scott Friedman, the Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai
Play • 37 min

Causes of chronic liver diseases, emerging treatments, COVID-19

Dr. Scott Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.

--- Send in a voice message: https://anchor.fm/scientificsense/message Support this podcast: https://anchor.fm/scientificsense/support
More episodes
Search
Clear search
Close search
Google apps
Main menu